Impact of soluble HLA-G levels and endometrial NK cells in uterine flushing samples from primary and secondary unexplained infertile women

International Journal of Molecular Sciences

Volumn 16, Issue 3, 2015, Pages 5510-5516

  Rizzo, Roberta ^a   Lo Monte, Giuseppe ^a,b   Bortolotti, Daria ^a   Graziano, Angela ^a,b   Gentili, Valentina ^a   Di Luca, Dario ^a   Marci, Roberto ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

CD158d (KIR2DL4); Endometrial natural killer; Primary infertility; Secondary infertility; Soluble human leukocyte antigen (sHLA G); Uterine flushing

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; FOLLITROPIN; HLA G ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; LUTEINIZING HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CELL ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; FLOW CYTOMETRY; FLUSHING; HUMAN; MENSTRUAL CYCLE; NATURAL KILLER CELL; PROTEIN CONTENT; SENSITIVITY ANALYSIS; UTERINE FLUSHING; CASE CONTROL STUDY; ENDOMETRIUM; GENETICS; METABOLISM; PATHOLOGY;

ADULT; CASE-CONTROL STUDIES; ENDOMETRIUM; FEMALE; HLA-G ANTIGENS; HUMANS; INFERTILITY, FEMALE; KILLER CELLS, NATURAL;

EID: 84925876733     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16035510     Document Type: Article

References (12)

1. Moffett-King, A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002, 2, 656–663.
2. Geiselhart, A.; Dietl, J.; Marzusch, K.; Ruck, P.; Ruck, M.; Horny, H.P.; Kaiserling, E.; Handgretinger, R. Comparative analysis of the immunophenotypes of decidual and peripheral blood large granular lynphocytes and T cells during early human pregnancy. Am. J. Reprod. Immunol. 1995, 33, 315–322.
3. Gonen-Gross, T.; Goldman-Wohl, D.; Huppertz, B.; Lankry, D.; Greenfield, C.; Natanson-Yaron, S.; Hamani, Y.; Gilad, R.; Yagel, S.; Mandelboim, O. Inhibitory NK receptor recognition of HLA-G: Regulation by contact residues and by cell specific expression at the fetal-maternal interface. PLoS One 2010, 5, e8941.
4. Rizzo, R.; Bortolotti, D.; Baricordi, O.R.; Fainardi, E. New insights into HLA-G and inflammatory diseases. Inflamm. Allergy Drug Target 2012, 11, 448–463.
5. Rizzo, R.; Stignani, M.; Melchiorri, L.; Baricordi, O.R. Possible role of human leukocyte antigen-G molecules in human oocyte/embryo secretome. Hum. Immunol. 2009, 70, 970–975.
6. Dahl, M.; Perin, T.L.; Djurisic, S.; Rasmussen, M.; Ohlsson, J.; Buus, S.; Lindhard, A.; Hviid, T.V. Soluble human leukocyte antigen-G in seminal plasma is associated with HLA-G genotype: Possible implications for fertility success. Am. J. Reprod. Immunol. 2014, 72, 89–105.
7. Emmer, P.M.; Steegers, E.A.; Kerstens, H.M.; Bulten, J.; Nelen, W.L.; Boer, K.; Joosten, I. Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies. Hum. Reprod. 2002, 17, 1072–1080.
8. Kotze, D.; Kruger, T.F.; Lombard, C.; Padayachee, T.; Keskintepe, L.; Sher, G. The effect of the biochemical marker soluble human leukocyte antigen G on pregnancy outcome in assisted reproductive technology—A multicenter study. Fertil. Steril. 2013, 100, 1303–1309.
9. Le Bouteiller, P. HLA-G in human early pregnancy: Control of uterine immune cell activation and likely vascular remodeling. Biomed. J. 2015, 38, 32–38.
10. Perricone, R.; Perricone, C.; de Carolis, C.; Shoenfeld, Y. NK cells in autoimmunity: A two-edg’d weapon of the immune system. Autoimmun. Rev. 2008, 7, 384–390.
11. Mikołajczyk, M.; Skrzypczak, J.; Szymanowski, K.; Wirstlein, P. The assessment of LIF in uterine flushing: A possible new diagnostic tool in states of impared fertility. Reprod. Biol. 2003, 3, 259–270.
12. Gonzalez, A.; Alegre, E.; Arroyo, A.; LeMaoult, J.; Echeveste, J.I. Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-like molecules in exudates. Clin. Chem. 2011, 57, 1013–1022.